Clinical Trial Update: Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 trial update for cabozantinib in advanced radioactive-iodine refractory differentiated thyroid cancer; the study is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Grupo Espanol de Tumores Neuroendocrinos | Conditions: Differentiated Thyroid Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING